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Telomeres protect chromosome ends through the
interaction of telomeric repeats with shelterin,
a protein complex that represses DNA damage
signaling and DNA repair reactions. The telomeric
repeats are maintained by telomerase, which solves
the end replication problem. We report that the
TTAGGG repeat arrays of mammalian telomeres
pose a challenge to the DNA replication machinery,
giving rise to replication-dependent defects that
resemble those of aphidicolin-induced common
fragile sites. Gene deletion experiments showed
that efficient duplication of telomeres requires the
shelterin component TRF1. Without TRF1, telomeres
activate the ATR kinase in S phase and show a
fragile-site phenotype in metaphase. Single-mole-
cule analysis of replicating telomeres showed that
TRF1 promotes efficient replication of TTAGGG
repeats and prevents fork stalling. Two helicases
implicated in the removal of G4 DNA structures,
BLM and RTEL1, were required to repress the
fragile-telomere phenotype. These results identify a
second telomere replication problem that is solved
by the shelterin component TRF1.
INTRODUCTION
Mammalian chromosome ends feature long arrays of TTAGGG
repeats that serve as binding sites for shelterin (de Lange,
2005), a telomere-specific protein complex that represses
the DNA damage response. The stability of mammalian chromo-
somes and indeed cell viability critically depends on the mainte-
nance of sufficient shelterin binding sites at each telomere.
Telomeric DNA can be lost with cell proliferation because of
the inability of the DNA replication machinery to duplicate DNA
ends. This end replication problem is solved by telomerase,90 Cell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc.the reverse transcriptase that adds telomeric repeats onto the
30 ends of chromosomes (Greider and Blackburn, 1985), thereby
compensating for terminal sequence loss. Most of the long
TTAGGG repeat array at the ends of mammalian chromosomes,
however, is maintained by semiconservative DNA replication.
Our data reveal that telomeric repeats pose a challenge to the
DNA replication machinery, giving rise to replication-dependent
defects that resemble those of aphidicolin-induced common
fragile sites.
Fragile sites represent specific chromosomal regions that chal-
lenge replication, especially under conditions of limiting nucleo-
tide pools or partial inhibition of DNA polymerases (Durkin and
Glover, 2007). Examples are the common fragile sites, which
are prone to display abnormal features in metaphase chromo-
somes when cells experience replication stress. Specifically,
treatment with low levels of the DNA polymerase inhibitor aphidi-
colin induces site-specific breaks or gaps inmetaphase chromo-
somes (Glover et al., 1984). Themolecular basis of this replication
dependent instability is not known. Common fragile sites are
large, and sequence motifs that might explain their behavior
have not been identified. The occurrence of breaks or gaps at
common fragile sites is enhanced when replication stress is
combined with deficiency in the ATR kinase pathway, which
responds to stalled replication forks (Casper et al., 2002). Simi-
larly, inhibition of homology-directed repair, which facilitates
replication restart after replication fork collapse, exacerbates
the expression of common fragile sites (Arlt et al., 2004). The
idea that common fragile sites represent regions where replica-
tion forks stall and collapse is consistent with the increased
rate of recombination at these loci (Feichtinger and Schmid,
1989; Glover and Stein, 1987). Indeed, common fragile sites are
hotspots for deletions and other chromosome rearrangements
in cancer (Yunis and Soreng, 1984; LeBeau and Rowley, 1984).
Our data identify telomeres as aphidicolin-induced fragile sites
and establish that the shelterin protein TRF1 is required to
prevent telomere replication problems. TRF1 is one of the six
distinct proteins that make up shelterin (Chong et al., 1995; re-
viewed in de Lange, 2005). TRF1 and its paralogs, TRF2, bind
to double-stranded TTAGGG repeats of the telomere with
high fidelity. Both proteins are abundant at telomeres, binding
throughout the telomeric DNA tract. TRF1 and TRF2 interact with
TIN2, which also recruits TPP1 and POT1 to chromosome ends.
POT1 also binds telomeric DNA, but unlike TRF1 and TRF2, it
interacts with the single-stranded TTAGGG repeats in the 30
overhang. TRF2 and POT1 contribute to the protection of chro-
mosome ends by repressing DNA damage signaling by the
ATM and ATR kinases, respectively (Denchi and de Lange,
2007). TRF2 and POT1 also repress the two main DNA repair
pathways, nonhomologous end joining (NHEJ) and homology-
directed repair (HDR) (Celli and de Lange, 2005; Celli et al.,
2006; Palm et al., 2009). Although TRF1 has a similar architecture
as TRF2 (Fairall et al., 2001), it has distinct domains and
A
B
D
G
E
F
C
Figure 1. Conditional Deletion of Mouse
TRF1
(A) Schematic of the mouse TRF1 locus on chro-
mosome 1 (NCBI locus ID 21749), the targeting
construct, and the altered alleles of TRF1. R,
EcoRI; P, PvuII; H, HindIII. F1, F2, and R, PCR
primers.
(B) TRF1 PCR on tail DNA from mice of the indi-
cated genotypes using the F1 and F2 forward
primers and the R reverse primer. PCR products:
wild-type, 100 bp; flox, 152 bp; null allele, 500 bp.
(C) Immunoblot monitoring loss of TRF1 upon Cre
treatment of TRF1F/F MEFs. TRF1 (Ab1449) was
detected 3 days after Cre treatment of TRF1F/F
and TRF1F/+ MEFs. Cre, mock infection; g-tubulin,
loading control.
(D) IF-FISH tomonitor TRF1at telomeres of TRF1F/F
MEFs at day 3 after Cre. TRF1 IF, red; telomeric
FITC PNA probe, green.
(E) Graph representing proliferation of TRF1-defi-
cient MEFs.
(F) Phase-contrast microscopic images of primary
TRF1F/F MEFs before and after Cre treatment.
Cells were stained for SA-b-galactosidase at day
7 after Cre.
(G) Metaphase spreads showing the fragile-telo-
mere phenotype in TRF1 null cells. Telomeres
were highlighted by FISH (green), and DNA was
stained with DAPI (red) at day 4 after Cre.
a different set of interacting partners
(Chen et al., 2008; reviewed in Palm and
de Lange, 2008). TRF1 has been shown
to contribute to telomere length regula-
tion (van Steensel and de Lange, 1997;
Smogorzewska et al., 2000), but its role
in telomere protection had not been es-
tablished. Because TRF1 deletion in the
mouse is lethal (Iwano et al., 2004; Karl-
seder et al., 2003), we generated a condi-
tional allele to examine the role of TRF1 in
telomere biology.
RESULTS
Conditional Deletion of TRF1
We generated a conditional allele of the
mouse TRF1 gene that allows Cre-medi-
ated deletion of exon 1, which contains the translation start
site (TRF1F; Figures 1A and 1B). Introduction of Cre into
TRF1F/F mouse embryo fibroblasts (MEFs) resulted in the ex-
pected loss of TRF1 protein within 72 hr (Figures 1C and 1D).
Consistent with previous reports on the lethality of TRF1 deletion
(Iwano et al., 2004; Karlseder et al., 2003), loss of TRF1 induced
a growth arrest and senescence in primary and SV40-LT immor-
talized MEFs (Figures 1E and 1F). As deletion of TRF1 was better
tolerated in immortalized MEFs, they were used for these
studies unless indicated otherwise. The cell-cycle arrest and
other phenotypes of Cre-mediated TRF1 deletion were sup-
pressed by exogenous TRF1 (Figure S1 available online, andCell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc. 91
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Figure 2. Effects of TRF1, Aphidicolin, and ATR shRNA
(A) Examples of the fragile telomeres in TRF1F/FMEFmetaphases at day 4 after
Cre. Telomeric DNA, FITC PNA probe (green); DNA, DAPI (blue).
(B) Quantification of fragile telomeres induced by deletion of TRF1 with or
without treatment with 0.2 mM aphidicolin or ATR shRNA. Bars represent
mean values of three independent experiments with SDs. Asterisks, p < 0.01
based on a two-tailed Student’s t test.
(C) Quantification of chromosome breaks/gaps. Experimental conditions are
as in (B).92 Cell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc.see below), demonstrating that they are indeed a consequence
of TRF1 loss.
TRF1-deficient cells did not show a strong telomere fusion
phenotype, as fewer than 2% of the metaphase chromosomes
became joined and genomic DNA analysis showed that both
the telomeric restriction fragment lengths and the telomeric 30
overhang were unaltered (Figures S2A and S2B). These results
contrast the phenotype of TRF2 deletion, which induces telo-
mere fusions and a concomitant loss of the 30 overhang (Celli
and de Lange, 2005). Deletion of TRF1 also did not lead to the
strong increase in telomeric overhang signals observed upon
deletion of POT1b, nor did the cells show the endoreduplication
phenotype associated with the loss of POT1a (Figures S2B and
S2C) (Hockemeyer et al., 2006). Furthermore, TRF1 deletion did
not change the expression levels of Rap1, POT1a, or TRF2
(Figures S2D and S2E and data not shown), and there were
only moderate effects on the association of Rap1, TRF2, TPP1,
and POT1a with telomeric DNA as measured by ChIP
(Figure S2F).
TRF1 Deletion Results in Aberrant Telomeres
in Metaphase
The most notable phenotype of TRF1 deletion was a high inci-
dence of telomeres with an aberrant structure in metaphase
(Figures 1G and 2A). The telomeric FISH signal at individual chro-
matid ends is normally represented as a single signal with an
intensity that is roughly equal to the telomeric signal of the sister
chromatid end. After TRF1 deletion, a large fraction of chroma-
tids had multiple telomeric signals (Figures 2A and 2B). In
some cases, the multiple signals were spatially separated from
the chromatid end, as if the telomeric DNA had failed to
condense or was broken. We refer to these various abnormal
telomeric patterns as fragile telomeres.
Up to 20% of the telomeres showed this aberrant structure in
TRF1 null cells, whereas fragile telomeres were less frequent
(<5%) in control cells (Figure 2B). Chromosome-orientation
FISH (CO-FISH) showed that both sister telomeres were roughly
equally prone to display the fragile phenotype (Figure S3A and
data not shown). Aberrant telomeric structures (often referred to
as telomere doublets) resembling the fragile telomeres docu-
mented here were previously reported in several settings,
including embryonic stem cells (ESCs) lacking TRF1 (Philippe
et al., 1999; Undarmaa et al., 2004; Iwano et al., 2004; van Over-
beek and de Lange, 2006; Blanco et al., 2007; Okamoto et al.,
2008), but the underlying telomeric defect hadnot been identified.
In addition to the fragile telomeres, we observed frequent
associations of sister telomeres in TRF1 null cells (Figure 2D).
These telomere associations did not result from NHEJ since
they also occurred upon deletion of TRF1 from cells lacking
DNA ligase IV (Figure 2D). The molecular nature of these associ-
ations remains to be determined, but, given the data presented
(D) Quantification of long arms telomere associations in response to the indi-
cated treatments. Experimental conditions are as in (B). Sister telomere asso-
ciations were only scored on long arms. Sister associations were significantly
reduced (p < 0.05 based on a two-tailed Student’s t test) by treatment of TRF1
null cells with ATR shRNA but not by aphidicolin treatment or absence of DNA
ligase IV (lig4/).
below, it is tempting to speculate that the sister telomere associ-
ations represent the recently described sister chromatid bridges
at fragile sites (Chan et al., 2009).
Fragile Telomeres Are Induced by Aphidicolin
and Respond to Inhibition of ATR
In order to test whether the fragile-telomere phenotype resem-
bles that of the common fragile sites, we examined metaphases
of wild-type MEFs treated with low concentrations of aphidicolin
(0.2 mM). Consistent with previous data (Glover et al., 1984),
aphidicolin induced breaks in 8% of chromosomes (Figures
2C, S3B, and S3C). Importantly, aphidicolin induced a striking
increase in the frequency of fragile telomeres (Figure 2B). The
effect of aphidicolin was additive with deletion of TRF1, resulting
in28% of telomeres showing this phenotype (Figure 2B). Aphi-
dicolin did not affect the sister telomere associations seen after
TRF1 deletion (Figure 2D).
In order to determine the effect of ATR on the fragile-telomere
phenotype, TRF1F/F MEFs were treated with Cre and subse-
quently with ATR short hairpin RNA (shRNA) (Figure S3D). As
for the common fragile sites (Casper et al., 2002), ATR inhibition
strongly enhanced the fragile-telomere phenotype of TRF1-defi-
cient cells (Figures 2B and S3B–S3E). In contrast, inhibition of
ATR did not increase the sister telomere association phenotype
of TRF1 null cells (Figure 2D). Collectively, the data obtained with
cells treated with aphidicolin or ATR shRNA demonstrate that
telomeres resemble common fragile sites and that this feature
of telomeres is partially repressed by TRF1.
S Phase-Dependent ATR Signaling upon Loss of TRF1
Consistent with a DNA replication defect, cells lacking TRF1
showed a strong telomere damage response phenotype, as evi-
denced by 53BP1 and g-H2AX telomere dysfunction-induced
foci (TIFs) (Takai et al., 2003) (Figures 3A, 3B, and S4). The TIF
response was fully repressed by exogenous TRF1, establishing
that it was due to TRF1 loss (Figure S1). Using MEFs with
compound genotypes, we determined whether this DNA
damage signal depended on the ATM, DNA-PKcs, or ATR
kinase. Of these three kinases, only ATR was required for the
TIF response (Figures 3A, 3B, and S5). Consistent with ATR
signaling, Chk1 became phosphorylated upon deletion of
TRF1, whereas phosphorylation of the ATM target Chk2 was
not detected (Figures 3C and 3D).
We next asked whether progression through S phase was
required for the activation of ATR at telomeres lacking TRF1.
To test this, we deleted TRF1 from quiescent (G0) primary
TRF1F/ cells. As a positive control, TRF2, which is known to
be required for telomere protection in all stages of the cell cycle
(Konishi and de Lange, 2008), was deleted from a parallel culture
of quiescent primary TRF2F/ cells. While deletion of TRF2 re-
sulted in the expected 53BP1 foci at telomeres, the TIF response
was minimal in G0 cells lacking TRF1 (Figures 3A, 3B, and S5).
TIFs only became prominent when the cells were released
from G0 and progressed through S phase (Figures 3E and S5).
These results demonstrate that progression through S phase
in absence of TRF1 induces an ATR-dependent DNA damage
signal at telomeres. Asmost cells in an asynchronous population
of immortalized TRF1 null cells showed numerous TIFs, it is likelythat much of the DNA damage generated at telomeres in S phase
persists when TRF1 is absent.
Analysis of Telomere Replication in Wild-Type
Cells using SMARD
We used SMARD (single-molecule analysis of replicated DNA;
Norio and Schildkraut [2001]) to examine the progression of
replication forks through telomeric DNA (Figure 4A). SMARD
relies on two sequential periods of in vivo labeling with different
halogenated nucleotides (IdU and CldU) to mark replicating DNA
molecules. Genomic DNA from the labeled cells was digested
with frequently cutting restriction enzymes that cleave most of
the genomic DNA into small fragments but do not cut in the
long (>20 kb) TTAGGG repeat arrays, so that DNA fragments
with a molecular weight (MW) >25 kb isolated from an agarose
gel were enriched for telomeric DNA. The incorporation of IdU
and CldU was visualized with fluorescent antibodies in partially
denatured DNA molecules stretched onto silanized glass slides.
We identified the telomeric DNA fragments with a FISH-PNA
probe (TelC) that anneals to the G-rich telomeric repeat strand.
Although annealing of the TelC probe interferes with detection
of the IdU and CldU in the TTAGGG repeats, substitutions in
the CCCTAA repeat strand are detectable. Both the telomeric
FISH signal and the IdU or CldU fluorescent signals appeared
as strings of dots that were often interrupted due to the partial
denaturation of the DNA (Figure 4A). Nonetheless, long telomeric
DNA molecules were readily identified among the mixture of
DNA fragments. The optimized procedure used pulse-labeling
periods of 30 min followed by a 3 hr chase. Since this procedure
only labels the DNA in cells that are in S phase during the pulses,
the protocol was further improved by repeating the pulse-chase
six times. The total duration of the six rounds of pulse/chase was
21 hr, which is less than the cell doubling time. As replication
forks progress at 2 kb/min (Anglana et al., 2003), even the
longest telomeres (150 kb) should be fully replicated within
one round of the double-pulse/chase procedure. As expected,
the average length of the IdU and CldU segments was approxi-
mately equal, and the two substitutions were observed in
approximately equal fractions of the telomeric DNA molecules.
Because the telomeric DNA fragments used for the analysis
are of variable lengths, the rate of fork progression cannot be
determined accurately in these experiments. However, given
that we frequently observed telomeric fragments in the >25 kb
size range that were completely labeled with either IdU or CldU
in experiments using 30 min pulses, it is unlikely that the fork
rate is lower than 1 kb/min.
The final protocol yielded telomeric DNA molecules with
a pattern of IdU/CldU incorporation that could be consistent
with replication proceeding from a subtelomeric origin toward
the chromosome end (Figure 4A). To determine the direction of
the replication fork, we analyzed telomeric DNA molecules with
an attached segment of subtelomeric DNA generated by diges-
tion with SwaI (Figure 4B). The length of the telomeric SwaI frag-
ments is 180 kb as identified by genomic blotting (see inset in
Figure 4B). In this size fraction of SwaI-digested DNA, the telo-
meric fragments are not strongly enriched, limiting the number
of telomeric molecules available for analysis. Nonetheless, we
identified 90 telomeric SwaI restriction fragments, which hadCell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc. 93
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Figure 3. Deletion of TRF1 Results in an S Phase-Dependent ATR Kinase Signal
(A) ATR-dependent TIF formation upon deletion of TRF1 from cycling cells. Cells with the indicated genotypes were analyzed at day 4 after pWZL-Cre using FISH
for telomeres (green), IF for 53BP1 (red), and DAPI DNA counterstain (blue). So that the lethality associated with ATR deletion could be circumvented, the TRF1F/F
ATRF/F cells were arrested in G0 by contact inhibition and serum starvation, infected with Ad-Cre, released at day 3, and analyzed 1 day later. For the two right-
hand panels, TRF1F/ and TRF2F/ cells were similarly arrested in G0 and infected with Ad-Cre, but were analyzed at 4 day while in G0. Deletion of ATR, TRF1, and
TRF2 was verified by immunoblotting (Figure S5).
(B) Quantification of the TIF response as shown in (A). Bargraphs represent mean values of three independent experiments and SDs. Asterisks, p < 0.01 based on
a two-tailed Student’s t test.
(C) Immunoblot for Chk1 phosphorylation. Cells with the indicated genotypes were analyzed at day 6 after Cre. POT1a null MEFs and cells treated with UV
(25 J/m2, 30 min recovery) serve as positive controls.
(D) Immunoblot for Chk2 phosphorylation. Cells were treated as in (C). MEFs treated with IR (2 Gy,1 hr recovery) serve as a positive control.
(E) S phase-dependent induction of TIFs. TRF1F/F cells were synchronized in G0 and infected with Ad-Cre and analyzed as in (A). For G1, cells were released into
normal medium on day 3 after Cre and harvested 15 hr after release. S/G2 cells were released into normal medium followed by an aphidicolin block and analyzed
7 hr after release from the G1/S block. Bar graphs represent mean values of three independent experiments and SDs. TRF1 was deleted in 50% of the cells
(Figure S5). FACS analysis of the G0, G1, and S/G2 cells is shown in Figure S5.a labeled (IdU or CldU) segment that extended beyond the telo-
meric DNA labeled with FISH (Figure 4B). The presence of IdU or
CldU in the subtelomeric segment and the absence of substitu-94 Cell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc.tion in the distal end of the molecules is consistent with progres-
sion of the replication fork from a subtelomeric site into the
telomeric DNA. We also observed molecules with IdU in the
subtelomeric segment that contained IdU at the proximal end
and CldU at the distal end. Again, this configuration is consistent
with replication from a subtelomeric origin.
Occasional Replication Initiation within Telomeric
Repeats in Wild-Type Cells
We observed a small number of telomeric DNAs that suggested
initiation of DNA replication within the telomeric repeats
(Figure 4C). These molecules contained an IdU segment flanked
on both sides by segments of CldU, indicating that replication
had started in the telomeric sequences during the IdU pulse
and continued in both directions during the CldU pulse. In
some cases, replication proceeded both from a subtelomeric
origin and an origin within the telomere, leading to convergence
of two forks within the telomeric repeats. The frequency of initi-
ation events within the telomeric DNA was low; only 3% of
telomeric molecules showed a pattern consistent this mode
of replication. Occasional initiation of DNA replication in the
telomeric repeat array is consistent with the relative lack of
sequence specificity of mammalian ORC (Falaschi et al., 2007).
In addition, the association of ORC components with shelterin
(Deng et al., 2007; Tatsumi et al., 2008; Atanasiu et al., 2006)
could contribute to formation of a prereplication complex within
the telomeric DNA.
Diminished Telomeric Replication upon Deletion
of TRF1
To determine whether TRF1 affected the efficiency of telomere
replication,wemeasured the fractionof telomericDNAmolecules
that contained either IdU or CldU (or both) in DNA obtained from
TRF1-proficient and -deficient cells (Figure 5). In three indepen-
dent experiments, the deletion of TRF1 resulted in an 2-fold
lower incorporation of halogenated nucleotides in telomeric
DNA molecules regardless of their length. This effect was not
due to a general reduction in DNA replication since the incorpora-
tionofBrdUwasnot alteredat the timepoint studied (FigureS2C).
As a control, the well-studied replicating region derived from the
Igh locus (Norio et al., 2005) was unaffected by deletion of TRF1
(Figure 5). Thus, deletion of TRF1 had a specific effect on the
replication of telomeric DNA. Furthermore, the efficiency of
telomere replication was not altered when TRF2 was deleted
from TRF2F/ Lig4/ MEFs (Figure 5), and deletion of TRF2 did
not induce a fragile-telomere phenotype (Celli and de Lange,
2005), indicating a specific role for TRF1 in facilitating telomere
replication.
Evidence for Replication Fork Stalling
Inspection of SwaI-digested telomeric DNA molecules, which
carry a subtelomeric DNA segment, revealed several cases of
IdU/CldU-labeling patterns consistent with replication fork stall-
ing in or before the telomeric DNA (Figure 6A). Among 97 telo-
meric molecules from TRF1-deficient cells, seven showed IdU
or CldU incorporation in the subtelomeric DNA but no incorpora-
tion in the telomeric segment. These patterns would indicate that
in the absence of TRF1, the fork has a greater tendency to stall
when it encounters telomeric DNA. Such molecules were not
identified among 78 telomeric SwaI fragments that were derived
in a parallel experiment with TRF1-proficient cells.Additional evidence for fork stalling was obtained from the
occasional molecules generated by replication initiation within
the telomeric repeats. We observed telomeric DNA molecules
with a nonterminal IdU segment thatwas short compared to other
molecules in the same experiment, indicative of initiation of repli-
cation in the telomericDNAat the endof the IdUpulse (Figure 6B).
In these molecules, the IdU segment is flanked on one side by
CldU, indicating forkprogressionduring theCldU-labelingperiod.
Importantly, a significant number of these molecules showed no
CldU incorporationat theother sideof the IdUsegment, indicating
that the forkon that sidedidnot progressduring theCldU-labeling
period. Although the number of this type of replication products
was small (14 out of 250 IdU- and/or CldU-labeled molecules),
they were never observed in DNA from TRF1-proficient cells
processed in parallel (400 IdU- and/or CldU-labeled molecules
examined), demonstrating again that absence of TRF1 impairs
the normal progression of the replication fork.
Fragile Telomeres in Human Cells
We next asked whether human telomeres also resemble fragile
sites. Since it is difficult to fully inactivate human TRF1 with
RNA interference (RNAi) or dominant-negative alleles, we deter-
mined whether treatment of human cells with aphidicolin
induced the fragile-telomere phenotype. Using the same low
level of aphidicolin applied to mouse cells, we observed an
increase in the frequency of fragile telomeres as compared to
untreated cells (Figure S7A). Thus, it is likely that human and
mouse telomeres are similar with regard to posing a challenge
to the replication fork.
Effect on Telomere Maintenance
We considered the possibility that the fragile-telomere pheno-
type might lead to loss of telomeric DNA. TRF1 null cells con-
tained a small fraction of chromosome ends that appeared to
lack telomeric signals, and this phenotype was somewhat
stronger when ATR was inhibited (Figure S2A). However, the
length of the telomeric restriction fragments of TRF1 null cells
was unaltered (Figure S2B). Because small telomere length
changes are difficult to detect in mouse cells, we addressed
the question of potential telomeric DNA loss in the human fibro-
sarcoma clone HTC75. We followed the effect of aphidicolin on
telomere length in HTC75 cells over 50 population doublings
(Figure S7C). As a control, parallel cultures were treated with
a concentration of zeocin that induced approximately the same
number of DNA damage foci per cell (Figure S7D). Neither zeocin
nor aphidicolin induced loss of the telomeric DNA in HTC75 cells.
Rather, aphidicolin, but not zeocin, resulted in moderate telo-
mere elongation (Figure S7B). Thus, the replication problems in
telomeres are not a major source of telomere loss in telome-
rase-positive cells, and they may even enhance the telomerase
pathway. In budding yeast, partial inhibition of DNA replication
also induces telomere elongation (Carson and Hartwell, 1985;
Adams and Holm, 1996).
The Mechanism by which TRF1 Represses
Telomere Fragility
As deletion of TRF1 but not TRF2 affected telomere replication,
we asked whether a specific feature of TRF1 was responsible forCell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc. 95
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Figure 5. Deletion of TRF1 Diminishes the Replication Efficiency of Telomeric DNA
SMARD assay results from three independent experiments in which TRF1 was deleted from TRF1F/FMEFs. Cells were labeled with IdU and CldU as indicated on
the right at day 4 after infectionwith H&RCre retrovirus (+Cre) or vector control (Cre). In the upper panel (experiments 1 and 2), DNAwas digestedwith frequently
cutting enzymes, and telomeric restriction fragments >25 kb were isolated (schematic on the left). Telomeric DNA molecules were identified by FISH, and the
percent of molecules containing IdU and/or CldU was determined. In the middle panel, telomeric MboI/AluI fragments in the 130–180 kb range (see genomic
blot inset) were isolated from a CHEF gel, and the fraction of telomeric molecules that contained IdU and/or CldU was determined as above. SMARD assay
was done in one experiment in which TRF2 was deleted from TRF2F/F DNA-Lig4/ cells and the fraction IdU- and/or CldU-labeled telomeric molecules
(130–180 kb range) was analyzed. In the lower panel, the DNA preparation of TRF1F/FMEFs used in themiddle panel was digested with SwaI and a 180 kb restric-
tion fragment from the Igh locus was isolated. DNA probes from that locus (see map below) were used to identify the Igh fragments on stretched DNA, and the
ratio of labeled versus unlabeled fragments was determined.its function. Although TRF1 is notably different from TRF2 in its
N-terminal domain, which is acidic, this domain was not respon-
sible for the repression of replication problems. TRF1DAc fully
repressed the fragile-telomere phenotype of TRF1 null cells,
whereas TRF1DMyb, which lacks the ability to bind to telomeric
DNA, was unable to complement the loss of the endogenous
TRF1 (Figures 7A and 7B). The repression of replication pro-
blems was also not due to a change in TERRA, a class of RNApolymerase II transcripts that contain UUAGGG repeats (Azzalin
et al., 2007). Although TRF1 was shown to be in a complex with
RNA polymerase II, and was suggested to contribute to TERRA
metabolism (Schoeftner and Blasco, 2008), no change in the
abundance of TERRA was observed in TRF1 null cells
(Figure 7B).
We next considered that TRF1 might repress replication prob-
lems by recruiting a class of helicases that can remove G4 DNAFigure 4. SMARD Analysis of Telomere Replication in Wild-Type Cells
(A) Top: schematic depiction of the SMARD protocol to visualize the replication of single telomeric DNA molecules. See text for description. Bottom: telomeric
DNA molecules of variable lengths identified by telomeric FISH (TelC; blue) with incorporated IdU and CldU detected with fluorescent antibodies (red and green,
respectively). The telomeric fragments are organized assuming that replication proceeds from a subtelomeric origin toward the chromosome end.
(B) Two examples of replication fork progression toward the chromosome end. SMARD on180 kb telomeric DNA SwaI fragments containing subtelomeric DNA
of variable lengths. The procedurewas as in (A), except that the DNAwas digestedwith SwaI and resolved on a pulse-field gel (see genomic blot inset). Duration of
the IdU and CldU pulses was 1 hr each. The pattern is consistent with replication forks progressing from a subtelomeric origin toward the chromosome end, as
depicted in the cartoon below each SMARD image.
(C) Examples of three telomeric molecules with IdU/CldU incorporation patterns consistent with replication initiating in the TTAGGG sequence. The procedure
was as in (A).Cell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc. 97
structures. G4 DNA can be formed by single-stranded TTAGGG
repeats and might impede the replication fork. One candidate
helicase is the BLM RecQ helicase, which contains the FxLxP
TRF1 binding motif (FILMP at aa 311 of human BLM), binds
TRF1 in vitro (Lillard-Wetherell et al., 2004), and binds and
unwinds G4 DNA (Sun et al., 1998; Huber et al., 2002; Huber
et al., 2006). Indeed, BLM-deficient mouse cells (Luo et al.,
2000) showed a high frequency of spontaneous fragile telomeres
(Figure 7C), whereas cells lacking another RecQ helicase, WRN,
did not show this phenotype. Furthermore, a BLM shRNA
induced the fragile-telomere phenotype, and this effect ap-
peared to be epistatic with TRF1 (Figures 7D and 7E). A second
candidate helicase that has been proposed to act on G-rich te-
lomeric DNA is RTEL1, which affects telomere length setting in
mouse species (Ding et al., 2004) and was recently shown to
be functionally similar to Srs2, a budding yeast helicase that
inhibit the Rad51 HDR pathway (Barber et al., 2008). Interest-
ingly, the published metaphases of RTEL1-deficient ESCs
show a mild fragile-telomere phenotype, although the frequency
of this phenotype was not reported (Ding et al., 2004). RTEL1
A
B
Figure 6. Evidence for Fork Stalling at Telo-
meres in Cells Lacking TRF1
(A) Evidence for replication fork stalling at the sub-
telomeric/telomeric boundary. Shown are four
SwaI DNA fragments containing telomeric repeats
and subtelomeric DNA from cells lacking TRF1. For
the procedure, see Figure 4. Molecules shown
represent incorporation patterns of IdU and CldU
consistent with replication of the subtelomeric
DNA (lacking TelC FISH signal) and fork stalling
at the boundary of subtelomeric and telomeric
DNA as shown in the schematic.
(B) Evidence for replication fork stalling after initia-
tion of DNA replication within telomeric DNA in
TRF1-deficient cells. DNA was cut with frequently
cutting restriction enzymes and molecules >25 kb
were isolated. Labeling was performed as in
Figure 5, top panel. The patterns of incorporation
of IdU and CldU are consistent with initiation of
replication within the telomeric DNA near the end
of an IdU pulse followed by fork progression in
only one direction during the CldU-labeling period.
shRNA induced fragile telomeres, and,
as was the case with BLM, this phenotype
appeared epistatic with deletion of TRF1
(Figures 7D and 7E). It will be necessary
to derive Blm/TRF1 DKO and Rtel1/
TRF1 DKO cells to further corroborate
that TRF1 acts by recruiting/activating
these helicases to telomeres.
DISCUSSION
Mammals employ TTAGGG repeats to
mark the ends of their chromosomes.
These repeats have been used to protect
chromosome ends throughout eukaryotic
evolution and remain the predominant
telomeric repeat in most eukaryotic phyla. Despite the obvious
utility of this sequence, there is a potential drawback of the
TTAGGG repeat-based telomere protection strategy, which we
report on here. Our data establish that the telomeric regions of
mouse and human chromosomes challenge DNA replication,
leading to a phenotype resembling common fragile sites.
Telomeres as Fragile Sites
Telomeres were not previously recognized as fragile sites, most
likely because their terminal position prohibits the observation of
the DNA distal to the gaps and breaks, unless the telomeric DNA
is highlighted by FISH. Telomeric FISH showed that telomeres
can attain a variety of aberrant structures, ranging from a simple
gap to long strings of fragmented telomeric signals or even an
extended strand of telomeric DNA. These cytological aspects
of the fragile-telomere phenotype are informative because they
provide direct observation of the aberrant structure. In contrast,
FISH probes that mark the center of instability of the very large
common fragile sites often do not coincide with the actual breaks
or gaps, which can occur at a distance (Becker et al., 2002).98 Cell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc.
Since the structure of the fragile telomeres is highly varied, it is
unlikely that the underlying lesion is a simple double-stranded
DNA break. Our observations are more compatible with altered
packaging and/or condensation of the chromatin perhaps due
to extended areas of single-stranded DNA resulting from incom-
plete replication or processing of stalled forks.
The Origin of the Telomere Replication Problem
It will be important to determine what aspect of the telomeric
DNA is causing problems during DNA replication. The fragile-
telomere phenotype is not a consequence of late replication as
mammalian telomeres replicate throughout S phase (Ten Hagen
et al., 1990; Wright et al., 1999). We also consider it unlikely that
the terminal position of the TTAGGG repeats is responsible for
the fragile nature. First, it is clear from our data that fork arrest
is occurring at a substantial distance from the actual chromo-
some end. Furthermore, an aphidicolin-induced fragile site in
Chinese hamster chromosomes is at or near interstitial telomeric
DNA (Musio et al., 1996), suggesting that internally placed telo-
meric repeats can cause the same problems as terminal ones.
Similarly, TTAGGG repeats induce chromosome rearrange-
ments when introduced at an internal locus (Kilburn et al.,
2001). The problems caused by chromosome-internal TTAGGG
repeats also argue against the idea that the t loop structure plays
a role in the replication defects.
Another possibility is that the telomeric DNA itself does not
impair replication but becomes a challenge when bound to the
telomeric protein complex. For instance, the single-stranded
telomeric DNA binding protein POT1 may compete with RPA,
thereby hampering lagging strand DNA synthesis. However,
TTAGGG repeats also impair DNA replication in budding yeast
(R. Wellinger, personal communication). Since budding yeast
lacks shelterin, this result argues that TTAGGG repeats provide
an inherent problem to the replication fork, regardless of the
proteins bound or the presence of t loops.
We favor the view that the telomeric DNA is a problematic
substrate for the replication machinery, most likely due to forma-
tion of G-G Hoogsteen base-paired G4 DNA in the G-rich telo-
meric repeat strand. Our finding that BLM and RTEL1, two heli-
cases that have been implicated in the removal of G4 DNA,
repress the fragile-telomere phenotype is consistent with the
idea that the fork is primarily hindered by secondary structures
formed by theG-rich telomeric DNA. If correct, this would predict
that G4 ligands such as telomestatin and RHPS4 might induce
a fragile-telomere phenotype and that some of their effects on
the growth of tumor cells (Salvati et al., 2007; Tahara et al.,
2006; Gomez et al., 2006) may be due to their preferential inhibi-
tion of telomere replication.
The Function of TRF1
Within shelterin, TRF2 and POT1 proteins collaborate to repress
all DNA damage response pathways that threaten chromosome
ends: DNA damage signaling by the ATM and ATR kinases and
NHEJ- and HDR-mediated DSB repair. These functions are
needed throughout the cell cycle, and loss of TRF2 or POT1
proteins in G0, G1, S, or G2 result in a DNA damage response
(Celli and de Lange, 2005; Hockemeyer et al., 2006; Konishi
and de Lange, 2008) (T.d.L., unpublished data). In contrast,TRF1 has a specific function in S phase, facilitating the replica-
tion of telomeres, thereby preventing ATR activation and the
formation of fragile telomeres in metaphase.
Our data suggest that TRF1 primarily acts through the recruit-
ment of BLM and RTEL1, but other factors are not excluded.
Neither RTEL1 nor BLM were observed in an exhaustive PICh-
based analysis of proteins associated with HeLa cell telomeres,
although BLM was found at ALT telomeres (Dejardin and King-
ston, 2009). However, it is possible that the association of these
helicases is transient and therefore escapes detection.
Deletion of the presumed fission yeast ortholog of TRF1 and
TRF2, Taz1, results in a block in telomere replication (Miller
et al., 2006). When Taz1 is absent, 2D gels reveal an aberrant
class telomeric fragments, referred to as the ‘‘plume,’’ specu-
lated to represent replication problems. Deletion of Taz1 also re-
sulted in fork stalling at a chromosome-internal segment of telo-
meric DNA. Furthermore, the telomeres of taz1 cells are rapidly
lost and require constant resynthesis by telomerase. These find-
ings are consistent with a role for Taz1 in promoting replication
through telomeric DNA and further underscore the similarity of
fission yeast and mammalian telomeres (see also Miyoshi
et al., 2008).
Implications
The finding that mammalian telomeres resemble fragile sites
makes several predictions. Common fragile sites are prone to
sister chromatid exchanges, often undergo rearrangements,
and are frequent targets of integration of exogenous DNA (re-
viewed in Durkin and Glover, 2007). With regard to the first hall-
mark of common fragile sites, the fragile telomeres in TRF1 null
cells do not appear to undergo frequent telomere sister chro-
matid exchanges (T-SCEs; Figure S2). However, T-SCEs are
known to be repressed by TRF2 and POT1a/b, which remain
associated with telomeres in TRF1 null cells (Celli et al., 2006;
Palm et al., 2009).
With regard to the second hallmark of common fragile sites,
their propensity to undergo rearrangements, recent work on
focal deletions in colon carcinomas has been revealing. A large
fraction (16%) of focal deletions occur near telomeres (Scott
Powers, personal communication), consistent with genome rear-
rangements due to the fragile nature of telomeres and providing
a parallel with the tumor-like microdeletions at common fragile
sites (Arlt et al., 2009; Durkin et al., 2008). In addition, human
chromosome ends show frequent duplications in subtelomeric
sequences, and the rate of sister chromatid exchange is high
near the telomeres (reviewed by Riethman, 2008). Both
phenomena may be related to the fragile-telomere phenotype
described here.
Finally, with regard to the integration of foreign DNA into
common fragile sites, it is noteworthy that chromosome ends
are often enriched for mobile elements. For instance, a human
herpes virus (HHV-6) was recently show to preferentially inte-
grate in telomeres (P.G. Medveczky, personal communication),
and LINE-1 elements can transpose to telomeres in certain
hamster cell lines (Morrish et al., 2007). An extreme version of
telomere-tropic integration is found in the bdelloid rotifers, which
have chromosome ends littered with foreign DNA, including
mobile elements and DNA derived from horizontal gene transferCell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc. 99
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Figure 7. The Mechanism by which TRF1 Represses Telomere Fragility
(A) Frequency of fragile telomeres in Cre-treated TRF1F/F MEFs complemented with TRF1DAc or TRF1DMyb (see Figure S6A for metaphase spreads and TRF1
immunoblots).
(B) TERRA detected by northern blotting of RNA from cells with the indicated genotype at day 4 after Cre. Bottom: Ethidium bromide (EtBr) staining of rRNAs
serves as loading control.
(C) Fragile telomere incidence in cells lacking Blm and/or Wrn.
(D) Representative metaphase spreads from TRF1F/F MEFs (+ or  Cre treatment) infected with Blm and Rtel1 shRNAs as indicated.
(E) Quantification of fragile telomeres in TRF1F/FMEFs (+ orCre treatment) infected with Blm and Rtel1 shRNAs as indicated. See Figure S6 for validation of the
shRNAs.100 Cell 138, 90–103, July 10, 2009 ª2009 Elsevier Inc.
(Gladyshev et al., 2008). Although the preferred telomeric inva-
sion in the bdelloid rotifers and mammalian cells could be due
to addition of DNA to the termini of deprotected telomeres fol-
lowed by telomere healing by telomerase, it is also possible
that integration is biased by frequent replication fork arrest within
the telomeric repeat array. In the latter scenario, the invading
element is less likely to compromise telomere function. One
could speculate that frequent fork arrest in subtelomeric/telo-
meric regions could have adaptive value since it would provide a
safe sink for mobile elements that might otherwise invade more
precious parts of the genome. This could explain why throughout
eukaryotic evolution, telomeres have not evolved away from the
TTAGGG repeats that generate replication problems.
EXPERIMENTAL PROCEDURES
TRF1 Gene Targeting, Isolation of MEFs, and Cell
Culture Procedures
The mouse TRF1 locus was modified using standard gene targeting tech-
niques to generate the TRF1F and TRF genotypes shown in Figure 1. The tar-
geting vector contained a TK-neomycin cassette flanked by LoxP sites cloned
into a HindIII site in the first intron. A third LoxP site was introduced by insertion
of an oligonucleotide into a PvuII site upstream of exon 1. ESC clones with the
correct integration were identified by genomic blotting of HindIII-digested DNA
with a probe flanking the left arm of the construct. Cre recombinase was tran-
siently expressed in the clones to generate ES subclones that had lost the TK-
neomycin cassette but retained exon 1 flanked by LoxP sites (floxed allele, F),
and subclones that had lost both exon 1 and the TK-neomycin cassette (null
allele, ). Two ESC subclones for each allele were used to generate chimeras
that delivered offspring with the TRF1F/+ or TRF1+/ genotypes. TRF1 mice
were maintained in a mixed background (129/C57Bl6). Compound genotypes
were created by intercrosses of TRF1F/F with ATM+/, ATRF/, Lig4/, and
DNA-PKcs/ mice (Barlow et al., 1996; Brown and Baltimore, 2003; Gao
et al., 1998). MEFs were isolated from E13.5 embryos and immortalized with
pBabeSV40-LT (a gift from Greg Hannon). SV40-LT-immortalized Wrn/,
Blm/, andWrn/ Blm/mouse ear fibroblasts were a gift from Brad John-
son. Cre recombinase was introduced with Hit&Run-Cre, Ad5 CMV Cre, or
pWZL-Cre as described previously (Celli and de Lange, 2005). Aphidicolin
treatments (0.2 mM) were for 16 hr. shRNAs for Blm (shBLM3c; GGACCTG
CTGGAAGATTTA) and ATR (shATR3-1; Denchi and de Lange [2007]) were
introduced using four infections at 6 hr intervals with pSuperior puromycin
retrovirus. shRNA for Rtel1 (pLK0.1 from Open Biosystems) was introduced
using two lentiviral infections at 12 hr intervals.
Analysis of Telomeric DNA, IF, IF-FISH, Immunoblotting,
FACS, and SA-b-Gal Assays
Telomeric overhang signals and telomeric restriction fragment patterns were
determined by in-gel analysis as previously described (Celli and de Lange,
2005). FISH for telomeric DNA was performed with a C-strand PNA probe
on methanol/acetic acid-fixed metaphase spreads as previously described
(Dimitrova et al., 2008). For IF-FISH and immunoblotting, previously described
standardmethods were used (Celli and de Lange, 2005; Dimitrova et al., 2008).
For FACS analysis, cells were plated at 13 106 cells and harvested 24 hr later.
Tenmicromolar BrdU was added to the media 1 hr prior to harvesting. Fixation
was done with ice-cold 70% ethanol at 4C for >30 min. Cells were washed
twice with 0.5% BSA in PBS and resuspended in 0.4 ml 0.5% BSA in PBS
containing 5 mg propidium-iodide and RNaseA (100 mg/ml). Samples were
analyzed with a FACScalibur flow cytometer (Becton Dickinson) with FlowJo
software. SA-b-GAL staining was preformed for 8–16 hr at 37C as previously
described (Dimri et al., 1995).SMARD Assay
The SMARD assay was performed essentially as described previously (Norio
and Schildkraut, 2001). Cells were sequentially labeled with 25 mM IdU
(30 min or 1 hr) and 25 mM CldU (30 min or 1 hr) with three PBS washes in
between followed by incubation with media without IdU/CldU for 3 hr. This
process was repeated six times for 30 min pulses and three times for 1 hr
pulses. DNA isolation and processing for SMARD were as described previ-
ously (Norio and Schildkraut, 2001). DNA was stretched on microscope slides
coated with 3-aminopropyltriethoxysilane (Sigma). After stretching, the DNA
was denatured in alkali-denaturing buffer (0.1 N NaOH in 70% ethanol and
0.1% b-mercaptothanoland) for 8, 12, or 15 min and fixed by addition of
0.5% glutaraldehyde for 5 min. Telomeric DNA was identified by hybridization
with a Biotin-OO-(CCCTAA)4 PNA probe and Alexa Fluor 350-conjugated
NeutrAvidin antibody (Molecular Probes) followed by biotinylated anti-avidin
antibody (Vector). Halogenated nucleotides were detected with a mouse
anti-IdU monoclonal antibody (Becton Dickinson) and a rat anti-CldU mono-
clonal antibody (Accurate). Alexa Fluor 568-conjugated goat anti-mouse
(Molecular Probes) and Alexa Fluor 488-conjugated goat anti-rat were used
as secondary antibodies (Molecular Probes).
Telomeric ChIP Analysis
IP of telomeric chromatin was performed as previously described (Loayza and
de Lange, 2003) and analyzed by dot-blotting using a TTAGGG repeat probe
and a BamHI repeat probe as a negative control. Input DNAwas used to calcu-
late the% telomeric DNA brought down in the ChIPs. The following antibodies
were used as crude sera: TRF1, 1449 (rabbit polyclonal); TRF2, 1254 (rabbit
polyclonal); Rap1, 1252 (rabbit polyclonal); POT1a, 1220 (rabbit polyclonal);
and TPP1, 1150 (rabbit polyclonal).
TERRA Analysis
Total cellular RNAwas prepared with the RNeasyMini Kit (QIAGEN), according
to the manufacturer’s instructions, and northern blot analysis was performed
as previously described (Azzalin et al., 2007). Blots were prehybridized at
60C for 1 hr in Church mix (0.5 M Na2HPO4 [pH 7.2], 1 mM EDTA, 7% SDS,
and 1% BSA), followed by hybridization at 60C overnight with 800 bp telo-
meric DNA probe from pSP73Sty11 labeled with a C-strand primer, Klenow
polymerase, and a-[32P]-dCTP. The blot was exposed to a PhosphorImager
screen and scanned with Image-Quant software.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
seven figures and can be found with this article online at http://www.cell.
com/supplemental/S0092-8674(09)00721-1.
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